Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases

J Enzyme Inhib Med Chem. 2017 Dec;32(1):920-934. doi: 10.1080/14756366.2017.1344236.

Abstract

A diverse set of mono- and bis-sulfonamide was obtained via a direct, chemoselective sulfochlorination of readily available yet hitherto unexplored N-arylpyrazole template. Biochemical profiling of compounds thus obtained against a panel of human carbonic anhydrases (hCA I, hCA II, hCA IV and hCA VII) revealed a number of leads that are promising from the isoform selectivity prospective and exhibit potent inhibition profile (from nanomolar to micromolar range). The observed SAR trends have been rationalized by in silico docking of selected compounds into the active site of all four isoforms. The results reported in this paper clearly attest to the power of direct sulfochlorination as the means to create carbonic anhydrase focused sets in order to identify isoform selective inhibitors of closely related enzymes.

Keywords: Carbonic anhydrases; bis-sulfonamides; chemoselectivity; direct sulfochlorination; isoform selectivity; mono-sulfonamides.

MeSH terms

  • Carbonic Anhydrase Inhibitors / chemistry*
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrases / drug effects
  • Computer Simulation
  • Drug Evaluation, Preclinical
  • Halogenation*
  • Humans
  • Isoenzymes / drug effects
  • Molecular Docking Simulation
  • Pyrazoles / chemistry*
  • Pyrazoles / pharmacology*
  • Spectrum Analysis / methods
  • Structure-Activity Relationship
  • Sulfonamides / chemistry*
  • Sulfonamides / pharmacology*
  • Sulfur / chemistry*

Substances

  • Carbonic Anhydrase Inhibitors
  • Isoenzymes
  • Pyrazoles
  • Sulfonamides
  • Sulfur
  • Carbonic Anhydrases

Grants and funding

This research was supported by the Russian Scientific Foundation (project grant 14-50-00069).